Tyloxapol
SIGMA/T0307 - BioXtra
Synonym: 4-
CAS Number: 25301-02-4
MDL Number: MFCD00149002
Product Type: Chemical
anion traces | chloride (Cl-): <0.05% |
sulfate (SO42-): <0.6% | |
cation traces | Al: <0.0005% |
Ca: <0.0005% | |
Cu: <0.0005% | |
Fe: <0.001% | |
K: <0.005% | |
Mg: <0.0005% | |
Na: <0.5% | |
NH4+: <0.05% | |
Pb: <0.001% | |
Zn: <0.0005% | |
CMC | 0.018 mM |
description | non-ionic |
ign. residue | <1.0% |
impurities | <0.0005% Phosphorus (P) |
InChI | 1S/C14H22O.C2H6O2.CH2O/c1 |
InChI key | GWJOFBXSBDVUMH-UHFFFAOYSA |
product line | BioXtra |
Quality Level | 100 |
SMILES string | [H]C([H])=O.OCCO.CC(C)(C) |
transition temp | cloud point 94.3 °C |
Application: | Tyloxapol has been used in a study to assess the enhanced pulmonary absorption of recombinant human insulin. It has also been used in a study to investigate the metabolic pathways promoting intrahepatic fatty acid accumulation in methionine and choline deficiency. |
General description: | A nonionic liquid polymer of the alkyl aryl polyether alcohol type. Used as a surfactant. |
General description: | Tyloxapol is a biocompatible surfactant |
Packaging: | 5, 10, 50 g in glass bottle |
Symbol | GHS07 |
Signal word | Warning |
Hazard statements | H315 - H319 - H335 |
Precautionary statements | P261 - P264 - P271 - P280 - P302 + P352 - P305 + P351 + P338 |
Hazard Codes | Xi |
Risk Statements | 36/37/38 |
Safety Statements | 26-36 |
RIDADR | NONH for all modes of transport |
WGK Germany | WGK 2 |
Flash Point(F) | 235.4 °F - closed cup |
Flash Point(C) | 113 °C - closed cup |
UNSPSC | 12161900 |